Bayer anticipated that their experimental blood clot drug might generate more than 5 billion euros ($5.4 billion) in peak annual sales.
Alira Health, a worldwide healthcare consultancy, clinical research, and technology firm, has raised an additional US$58 million in cash, cementing its position as a global leader in humanising healthcare.
Crescendo Health, a real-world data firm, debuted this month with $3.4 million from Define Ventures and other investors.
As we wrap up 2022, 2023 is here with new challenges and exciting innovations. As the dynamics of healthcare shifted greatly post pandemic, it has become the most innovative sector.
By publishing key bioequivalence results on a prospect created to increase adherence to treatment regimens for kidney illness, Unicycive Therapeutics has paved the way for entering a space pursued by Sanofi and Takeda.
In a randomised trial of hypertension incidence prediction models, released in Scientific Reports, researchers found that there was no efficiency discrepancy between machine learning (ML) models and traditional methods, suggesting that ML-based risk forecast models can reliably predict hypertension.
The majority of the world’s most serious health issues are really related to diet. The main culprit behind mortality and disability around the globe is malnutrition.
The innovative health institute Mercy makes extensive use of telemedicine and remote patient monitoring, and the outcomes support the model’s efficacy.
Wishing our Colleagues, Customers, Partners and Readers a lovely festive season and a Happy New year.
The “Blueprint for Trustworthy AI Implementation Guidance and Assurance for Healthcare,” issued by the Coalition for Health AI (CHAI), presents suggestions for moral health artificial intelligence (AI) standards to enhance high-quality treatment and boost AI trustworthiness.
As healthcare companies create programs to combat food insecurity, the food as medicine concept has lately gained momentum.
The FDA rejected UCB’s much awaited psoriasis treatment bimekizumab as a result of problems with facility inspections, therefore the firm is now praising the medicine’s potential in a different use.
Bayer anticipated that their experimental blood clot drug might generate more than 5 billion euros ($5.4 billion) in peak annual sales.
Alira Health, a worldwide healthcare consultancy, clinical research, and technology firm, has raised an additional US$58 million in cash, cementing its position as a global leader in humanising healthcare.
Crescendo Health, a real-world data firm, debuted this month with $3.4 million from Define Ventures and other investors.
As we wrap up 2022, 2023 is here with new challenges and exciting innovations. As the dynamics of healthcare shifted greatly post pandemic, it has become the most innovative sector.
By publishing key bioequivalence results on a prospect created to increase adherence to treatment regimens for kidney illness, Unicycive Therapeutics has paved the way for entering a space pursued by Sanofi and Takeda.
In a randomised trial of hypertension incidence prediction models, released in Scientific Reports, researchers found that there was no efficiency discrepancy between machine learning (ML) models and traditional methods, suggesting that ML-based risk forecast models can reliably predict hypertension.
The majority of the world’s most serious health issues are really related to diet. The main culprit behind mortality and disability around the globe is malnutrition.
The innovative health institute Mercy makes extensive use of telemedicine and remote patient monitoring, and the outcomes support the model’s efficacy.
Wishing our Colleagues, Customers, Partners and Readers a lovely festive season and a Happy New year.
The “Blueprint for Trustworthy AI Implementation Guidance and Assurance for Healthcare,” issued by the Coalition for Health AI (CHAI), presents suggestions for moral health artificial intelligence (AI) standards to enhance high-quality treatment and boost AI trustworthiness.
As healthcare companies create programs to combat food insecurity, the food as medicine concept has lately gained momentum.
The FDA rejected UCB’s much awaited psoriasis treatment bimekizumab as a result of problems with facility inspections, therefore the firm is now praising the medicine’s potential in a different use.
Sign up for HealthGeniuses weekly newsletter
and stay ahead of the curve
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.